Clinical Trials Browser

Interventional × Lymphatic Metastasis × Nivolumab × Clear all

NCT03793166 2026-03-18

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Phase 3 Active not recruiting

Carcinoma, Renal Cell, Lymphatic Metastasis

NCT05504642 2023-04-18

CERAD-IMMUNE

Phase 2 Withdrawn

Uterine Cervical Neoplasms, Lymphatic Metastasis